Hepion Pharmaceuticals, Inc.
HEPA
Revenue
0.00
0.000.00%
6 Months ChangeAssets
6.01M
▼-9.98M▼-62.41%
3 Months ChangeLiabilities
2.45M
▼-6.02M▼-71.09%
3 Months ChangeFree Cash Flow
-8.21M
▲1.91M▲18.90%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-05
Form 8-K
ID: 0001493152-24-035076
2024-08-13
Form 10-Q
ID: 0001493152-24-031582
2024-08-07
Form 8-K
ID: 0001493152-24-030495
2024-07-22
Form 8-K
ID: 0001493152-24-028637
2024-05-21
Form 10-Q
ID: 0001628280-24-024560
2024-03-06
Form 8-K
ID: 0001493152-24-009028
2024-02-20
Form 8-K
ID: 0001493152-24-007222
2024-02-16
Form 8-K
ID: 0001104659-24-024738
2024-02-07
Form 8-K
ID: 0001104659-24-011616
2024-01-03
Form 8-K
ID: 0001104659-24-000860